Category: SF1

THE FRENCH APPROACH TO FIGHTING ANTIBIOTIC RESISTA...

Posted by admin | May 19, 2017 | 1, 2016, 2016 frontpage, Government engagement | 0

Register now

Posted by admin | May 19, 2017 | Uncategorized | 0

“Is that all?” Very little investment needed to sa...

Posted by admin | Sep 17, 2016 | Introduction | 0

Welcome

Posted by admin | Jul 11, 2016 | Introduction | 0

Introduction by Jean Carlet

Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0

2017

Governance against Antimicrobial Resistance in Africa: Confronting AMR when resources are limited – The example of Senegal

by admin | Jul 26, 2017 | 2017, 2017 - 2, Governance | 0

Professor Awa Marie Coll-Seck, Minister of Health and Social Action, Republic of Senegal; Professor Ibrahima Seck, Technical Adviser to the Minister of Health and Social Action, Republic of Senegal; Professor Ahmad Lyane Sow,...

MedTech Europe

by admin | Sep 5, 2017 | Supporters 2017 | 0
The OIE Commitment to overcoming Antimicrobial Resistance and why it is important

by admin | Jul 31, 2017 | 2017, 2017 - 3, One Health | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Economics and Innovation

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...

The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

2017

MedTech Europe

May 19, 2018

Institut Merieux

May 19, 2018

Less than one cent to save a patient fro...

Sep 21, 2017

A National Action Plan to Contain Antimi...

Sep 14, 2017

MedTech Europe

Sep 5, 2017

The Global Point Prevalence Survey ̵...

Jul 28, 2017

Because taking care is the essence of he...

Jul 28, 2017

Healthcare

Intensive care units as epicentres for antimicrobial resistance development

by admin | Jul 31, 2017 | 2017, Healthcare | 0

Dr Jean Carlet President, World Alliance Against Antibiotic Resistance and Professor Jan De Waele, Intensivist, Ghent University Hospital, Belgium Antimicrobial resistance (AMR) is rapidly increasing to a dangerous level...

Improving rational antibiotic treatment of common childhood conditions in Uganda

by admin | Jul 31, 2017 | 2017, Healthcare | 0
Infections in surgery – a key battleground to combat antimicrobial resistance

by admin | Aug 1, 2017 | 2017, Healthcare | 0
Potential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections

by admin | Aug 1, 2017 | 2017, Healthcare | 0

Economics and Innovation

Socioeconomics, antimicrobial use and antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

Molly Miller-Petrie Research Associate, CDDEP and Hellen Gelband, Associate Director for Policy, CDDEP Global patterns of health and disease vary by national economic status, and individual health and healthcare are also heavily...

The Economics of reducing antibiotic use to reduce antimicrobial resistance

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
The role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Containing antimicrobial resistance is a smart investment in global public health and wealth

by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0

All

Algérie : Programme de Prévention et de Contrôle des Infections à Bactéries Multi-Résistantes en milieu de soins

by admin | Feb 18, 2019 | 4f | 0

Le réseau algérien sur la résistance aux antimicrobiens a détecté des taux élevés de pharmacorésistance montrant, par exemple, que près d’une entérobactérie sur trois était productrice d’une...